Compare BNTX & OVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BNTX | OVV |
|---|---|---|
| Founded | 2008 | 2020 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.9B | 20.0B |
| IPO Year | 2019 | 2019 |
| Metric | BNTX | OVV |
|---|---|---|
| Price | $90.25 | $62.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 27 |
| Target Price | ★ $116.80 | $81.52 |
| AVG Volume (30 Days) | 1.1M | ★ 3.2M |
| Earning Date | 11-03-2026 | 11-03-2026 |
| Dividend Yield | N/A | ★ 1.81% |
| EPS Growth | N/A | ★ 13.54 |
| EPS | N/A | ★ 1.36 |
| Revenue | N/A | ★ $8,908,000,000.00 |
| Revenue This Year | N/A | $18.95 |
| Revenue Next Year | $1.33 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $79.81 | $36.81 |
| 52 Week High | $124.00 | $73.62 |
| Indicator | BNTX | OVV |
|---|---|---|
| Relative Strength Index (RSI) | 38.33 | 46.77 |
| Support Level | $79.81 | $56.66 |
| Resistance Level | $93.89 | $67.45 |
| Average True Range (ATR) | 2.49 | 2.23 |
| MACD | 0.04 | -0.35 |
| Stochastic Oscillator | 24.84 | 9.68 |
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
Ovintiv is an independent oil and gas producer focused on Canada's Montney and the US' Permian basins. Historically, it has been an acquisitive producer across numerous basins and plays but has divested and exited all but two. It remains an active buyer in the remaining footprint. The firm estimates that it has up to 20 and 15 years of inventory remaining in the Montney and Permian basins, respectively.